Insiders Fortress Biotech, Inc.

Equities

FBIO

US34960Q3074

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-17 EDT			5-day change	1st Jan Change
1.9 ^USD	+1.60%		-3.06%	-36.88%

05-15	Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-15	Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q1 Revenue $13M	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Eric Rowinsky Announces Not Stand for Re-Election to the Board of Fortress Biotech, Inc	01-26	CI
Fortress Biotech Insider Bought Shares Worth $2,664,776, According to a Recent SEC Filing	11-16	MT
Fortress Biotech Insider Bought Shares Worth $249,999, According to a Recent SEC Filing	11-16	MT
Fortress Biotech CEO Rosenwald Buys 20,000 Shares for $210,900	23-08-21	MT
Fortress Biotech, Inc. Appoints Lucy Lu, M.D., to Its Board of Directors	22-12-19	CI
Urica Therapeutics, Inc Appoints Seasoned Biotech Executive Jay D. Kranzler, M.D., Ph.D., as Chairman and Chief Executive Officer	22-10-03	CI
Fortress Biotech Names David Jin as CFO	22-07-22	MT
Fortress Biotech Inc. Appoints David Jin as Chief Financial Officer	22-07-22	CI
Fortress Biotech, Inc. Appoints Kevin L. Lorenz, J.D. as a New Member of the Board	19-08-19	CI
Fortress Biotech Inc Appoints Robyn Hunter as Chief Financial Officer, Effective June 26, 2017	17-07-01	CI
Coronado Biosciences, Inc. will Change its Name to Fortress Biotech, Inc	15-04-28	CI
Coronado Biosciences Forms New Subsidiary Company, DiaVax Biosciences; Appoints Don J. Diamond to Chair the Scientific Advisory Board	15-04-02	CI
Coronado Biosciences, Inc. Announces Formation of New Subsidiary Company, Checkpoint Therapeutics; Appoints Wayne Marasco to its Scientific Advisory Board	15-03-04	CI
Coronado Biosciences, Inc. Forms Wholly Owned Subsidiary Journey Medical Corporation; Announces Executive Appointment for Journey Medical Corporation	14-10-08	CI
Coronado Biosciences, Inc. Appoints Michael S. Weiss as Executive Vice Chairman, Strategic Development	14-02-26	CI
Coronado Biosciences, Inc. Announces Executive Changes	14-01-29	CI
Coronado Biosciences, Inc. Announces Resignation of Michael Rogers as Director	13-12-26	CI
Coronado Biosciences, Inc. Announces Management Changes	13-12-20	CI
Coronado Biosciences Announces Appointment of Kevin Horgan as Chief Medical Officer	13-11-06	CI
Coronado Biosciences, Inc. to Appoint Hehenberger Coronado as Executive Vice President of Scientific Affairs	13-08-05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Fortress Biotech, Inc.

Equities

FBIO

US34960Q3074

Insiders

Filters